======================================================================
KAIROS ML PROTOTYPE V0 - AGE-DISEASE INTERSECTION ANALYSIS
Dataset: GSE114007 (Knee Cartilage OA vs Control)
Generated: 2025-12-26 22:41:23
======================================================================

STRATEGIC CONTEXT
----------------------------------------
Kairos: Causal gene-intervention discovery for aging biology
This analysis finds genes at the intersection of:
  1. Disease dysregulation (OA vs Control)
  2. Aging biology (GenAge, SenMayo, SASP signatures)
  3. MSC-deliverable (secreted factors)

AGING SIGNATURES USED
----------------------------------------
  GenAge (established aging genes): 75
  SenMayo (senescence markers): 93
  SASP (secretory phenotype): 98
  Combined unique genes: 192

INTERSECTION RESULTS
----------------------------------------
  OA-dysregulated genes: 1269
  Age-disease intersection: 34
  - Disease-elevated: 23
  - Protective loss: 11

MSC-DELIVERABLE CANDIDATES
----------------------------------------
  Secreted factors at intersection: 19
  - For restoration (MSC-delivered factor): 4
  - For inhibition (MSC-delivered antagonist): 15

INTERPRETATION NOTES
----------------------------------------
  ⚠️  Directionality is biologically context-dependent:

  SENESCENCE MARKERS (CDKN1A, GLB1, CDKN2B):
    - 'Down in OA' may NOT indicate loss of protection
    - Could reflect reduced senescent cell burden
    - Requires careful evaluation before targeting

  SASP FACTORS:
    - Restoration of pro-inflammatory factors could worsen disease
    - Flagged for careful evaluation in Notebook 06

  RISK FLAG SUMMARY:
    Low: 26 genes
    Evaluate carefully: 4 genes
    Context-dependent: 3 genes
    Inflammatory SASP: 1 genes

  AGING HALLMARK SUMMARY:
    ECM & Tissue Integrity: 9 genes
    Other / Mixed: 8 genes
    Senescence / Cell Cycle: 6 genes
    Inflammation / Immune: 6 genes
    Angiogenesis / Trophic: 5 genes

  PRIORITY FOR MSC DELIVERY (Notebook 06):
    1. Low-risk secreted factors (VEGFA, FST)
    2. MMP inhibitors (clear disease-elevated targets)
    3. Context-dependent factors require deeper analysis

TOP RESTORATION CANDIDATES (MSC-delivered factors)
----------------------------------------
  VEGFA: log2FC=-2.56
  LIF: log2FC=-1.80
  ANGPTL4: log2FC=-2.74
  FST: log2FC=-1.17

TOP INHIBITION CANDIDATES (MSC-delivered antagonists)
----------------------------------------
  MMP13: log2FC=3.20
  IGFBP3: log2FC=2.96
  SPP1: log2FC=2.51
  SERPINE2: log2FC=2.03
  MMP9: log2FC=1.42
  FN1: log2FC=1.40
  WNT5A: log2FC=1.35
  CTGF: log2FC=1.32
  VEGFC: log2FC=1.02
  THBS2: log2FC=2.50

OUTPUT FILES
----------------------------------------
  aging_gene_signatures.csv
  age_disease_intersection.csv
  secreted_candidates.csv
  age_disease_intersection.png
  secreted_candidates_plot.png
  hallmark_risk_summary.png

NEXT STEPS
----------------------------------------
  1. Notebook 06: Therapeutic Target Prioritization
  2. Rank candidates by druggability, effect size, aging evidence
  3. Build Streamlit demo for investors

======================================================================